我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
19
2 进行中
药物批准
0
批准总数
监管机构
监管机构数
成立时间
1785
已完成
13
68.4%
尚未招募
2
10.5%
招募中
3
15.8%
Unknown
1
5.3%
暂无批准数据
- A Zhejiang University team engineered brewer's yeast to produce 164.9 mg/L of catharanthine, the direct precursor to the anticancer drug vinblastine, inside a fermenter. - This output is nearly 1,000 times higher than any previously published global figure, breaking a decades-long supply bottleneck for the costly drug. - Vinblastine has been sourced exclusively from the Madagascar periwinkle, requiring up to 2 tonnes of dried leaves to yield just 1 gram, making it more expensive than gold by weight. - The findings, led by Professor Lian Jiazhang with collaborators in Canada and Westlake University, were published in the peer-reviewed journal Science on July 16.